ConductScience.org, home

Paper8229682

Targeting the systemic exposure of teniposide in the population and the individual using a stochastic therapeutic objective.

D'Argenio DZ and 1 other. J Pharmacokinet Biopharm, 1993. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Targeting the systemic exposure of teniposide in the population and the individual using a stochastic therapeutic objective. Papers, record 8229682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8229682

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting the systemic exposure of teniposide in the population and the individual using a stochastic therapeutic objective.
PubMed
Journal
J Pharmacokinet Biopharm
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.51
iCite
Revised in PubMed
2019-10-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1D'Argenio DZD Z
2Rodman JHJ H

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TeniposideMajor topic
Drug Monitoring
Feedback
Humans
Models, Biological
Population
Treatment Outcome

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 20180NCI NIH HHSUnited StatesP01CA020180PubMed and NIHNIH RePORTER
P30 CA21765NCI NIH HHSUnited StatesP30CA021765PubMed and NIHNIH RePORTER
P41 RR01861NCRR NIH HHSUnited StatesP41RR001861PubMed and NIHNIH RePORTER

Download CSV of grants

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11999001Pharmacokinetics of continuous-infusion amsacrine and teniposide for the treatment of relapsed childhood acute nonlymphocytic leukemia.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1999001PubMed
28426206Escalating teniposide systemic exposure to increase dose intensity for pediatric cancer patients.J Clin Oncol1993https://conductscience.org/library/papers/8426206PubMed
33905164Feedback control methods for drug dosage optimisation. Concepts, classification and clinical application.Clin Pharmacokinet1985https://conductscience.org/library/papers/3905164PubMed
41137256Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations.Ann Intern Med1975https://conductscience.org/library/papers/1137256PubMed
53297462The clinical pharmacology of etoposide and teniposide.Clin Pharmacokinet1987https://conductscience.org/library/papers/3297462PubMed
67152739Methods for evaluating optimal dosage regimens and their application to theophylline.Int J Clin Pharmacol Ther Toxicol1982https://conductscience.org/library/papers/7152739PubMed
72134510Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments.Math Biosci1990https://conductscience.org/library/papers/2134510PubMed
83598607Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.J Clin Oncol1987https://conductscience.org/library/papers/3598607PubMed
96958957VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.Med Pediatr Oncol1982https://conductscience.org/library/papers/6958957PubMed
10529025A priori lithium dosage regimen using population characteristics of pharmacokinetic parameters.J Pharmacokinet Biopharm1979https://conductscience.org/library/papers/529025PubMed
113806374Implementation and evaluation of control strategies for individualizing dosage regimens, with application to the aminoglycoside antibiotics.J Pharmacokinet Biopharm1986https://conductscience.org/library/papers/3806374PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
37111566From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure.Pharmaceutics2023https://conductscience.org/library/papers/37111566PubMed
31481443Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize A Priori Pharmacokinetic/Pharmacodynamic Target Attainments in Individual Patients.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31481443PubMed
27585476A Nonparametric Method to Optimize Initial Drug Dosing and Attainment of a Target Exposure Interval: Concepts and Application to Busulfan in Pediatrics.Clin Pharmacokinet2017https://conductscience.org/library/papers/27585476PubMed
18611060Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology.Clin Pharmacokinet2008https://conductscience.org/library/papers/18611060PubMed
10214563Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile.J Pharmacokinet Biopharm1998https://conductscience.org/library/papers/10214563PubMed
7473080Comparison of some control strategies for three-compartment PK/PD models.J Pharmacokinet Biopharm1994https://conductscience.org/library/papers/7473080PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8229682

GET https://conductscience.org/api/papers/v1/8229682/authors